Therapy for staphylococcus aureus

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/14 (2006.01) A61P 31/04 (2006.01) C07K 9/00 (2006.01)

Patent

CA 2301589

The present invention is directed to methods for treating infections caused by <u>Staphylococcus aureus</u> with reduced glycopeptide sensitivity. The invention is preferably practiced with strains of <u>Staphylococcus aureus</u> which are methicillin resistant, such as the Mu50 strain.

La présente invention concerne des méthodes de traitement d'infections provoquées par un staphylocoque doré présentant une sensibilité réduite aux glycopeptides. L'invention s'utilise, de préférence, avec des souches de staphylocoque doré qui sont résistantes à la méthicilline, comme la couche Mu50.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapy for staphylococcus aureus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapy for staphylococcus aureus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy for staphylococcus aureus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1914452

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.